Argentina Non-alcoholic Steatohepatitis Market (2025-2031) | Analysis, Growth, Companies, Segmentation, Forecast, Share, Outlook, Industry, Size & Revenue, Trends, Competitive Landscape, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Argentina Country Macro Economic Indicators

3.2 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, 2021 & 2031F

3.3 Argentina Non-alcoholic Steatohepatitis Market - Industry Life Cycle

3.4 Argentina Non-alcoholic Steatohepatitis Market - Porter's Five Forces

3.5 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F

3.7 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Disease Cause, 2021 & 2031F

3.8 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Argentina

4.2.2 Growing awareness about NASH among healthcare professionals and patients

4.2.3 Advancements in diagnostic technologies for early detection of NASH

4.2.4 Rising healthcare expenditure and government initiatives to address liver diseases

4.3 Market Restraints

4.3.1 Limited availability and high cost of NASH treatment options in Argentina

4.3.2 Lack of standardized guidelines for NASH management

4.3.3 Challenges in accurately diagnosing NASH due to overlapping symptoms with other liver conditions

4.3.4 Regulatory hurdles and delays in drug approvals for NASH therapies

6.1 Argentina Non-alcoholic Steatohepatitis Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Vitamin E and Pioglitazone, 2021- 2031F

6.1.4 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Ocaliva, 2021- 2031F

6.1.5 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Elafibranor, 2021- 2031F

6.1.6 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Selonsertib and Cenicriviroc, 2021- 2031F

6.1.7 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obeticholic Acid, 2021- 2031F

6.1.8 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Others, 2021- 2031F

6.2 Argentina Non-alcoholic Steatohepatitis Market, By Sales Channel

6.2.1 Overview and Analysis

6.2.2 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.2.3 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Online Providers, 2021- 2031F

6.2.4 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.3 Argentina Non-alcoholic Steatohepatitis Market, By Disease Cause

6.3.1 Overview and Analysis

6.3.2 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hypertension, 2021- 2031F

6.3.3 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Heart Disease, 2021- 2031F

6.3.4 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By High Blood Lipid, 2021- 2031F

6.3.5 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F

6.3.6 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obesity, 2021- 2031F

6.4 Argentina Non-alcoholic Steatohepatitis Market, By End User

6.4.1 Overview and Analysis

6.4.2 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Argentina Non-alcoholic Steatohepatitis Market Revenues & Volume, By Homecare settings, 2021- 2031F

7.1 Argentina Non-alcoholic Steatohepatitis Market Export to Major Countries

7.2 Argentina Non-alcoholic Steatohepatitis Market Imports from Major Countries

8.1 Average time to diagnose NASH in Argentina

8.2 Number of healthcare professionals trained in NASH management

8.3 Patient adherence rate to NASH treatment regimens

8.4 Percentage of NASH patients with access to specialized care

8.5 Rate of adoption of non-invasive diagnostic tools for NASH

9.1 Argentina Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 Argentina Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Sales Channel, 2021 & 2031F

9.3 Argentina Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Disease Cause, 2021 & 2031F

9.4 Argentina Non-alcoholic Steatohepatitis Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 Argentina Non-alcoholic Steatohepatitis Market Revenue Share, By Companies, 2024

10.2 Argentina Non-alcoholic Steatohepatitis Market Competitive Benchmarking, By Operating and Technical Parameters